Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4B | Q07343 | 3/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | KDM1A | O60341 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.40 |
| ▸ | BTK | Q06187 | 1/20 | 0.38 |
| ▸ | PARP1 | P09874 | 1/20 | 0.38 |
| ▸ | GPR119 | Q8TDV5 | 3/20 | 0.38 |
| ▸ | STS | P08842 | 1/20 | 0.38 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29895888 | 1.00 | PDE4B (0.44) | PDE4BHTTKDM1ASMN1; SMN2NPC1 | |
| SCHEMBL17121774 | 1.00 | PDE4B (0.44) | PDE4BHTTKDM1ASMN1; SMN2NPC1 | |
| SCHEMBL19025000 | 0.91 | SMN1; SMN2 (0.44) | PDE4BHTTSMN1; SMN2NPC1RAB9A | |
| SCHEMBL19025002 | 0.91 | SMN1; SMN2 (0.44) | PDE4BHTTSMN1; SMN2NPC1RAB9A | |
| SCHEMBL18681346 | 0.88 | KDM1A (0.44) | PDE4BKDM1ABTKPARP1GPR119 | |
| SCHEMBL21983609 | 0.84 | KDM1A (0.40) | PDE4BKDM1ABTKPARP1GPR119 | |
| SCHEMBL17121775 | 0.83 | EGFR (0.54) | PDE4BHTTGPR119USP30 | |
| SCHEMBL28827657 | 0.83 | EGFR (0.54) | PDE4BHTTGPR119USP30 | |
| SCHEMBL29895897 | 0.83 | EGFR (0.54) | PDE4BHTTGPR119USP30 | |
| SCHEMBL16895479 | 0.80 | PARP1 (0.43) | HTTSMN1; SMN2NPC1RAB9ACYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114989140-A | Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment of cancer | 卡佩拉医疗公司 | 2022-09-02 | — | — | CN | disclosed |
| CN-114940673-A | Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment of cancer | 卡佩拉医疗公司 | 2022-08-26 | — | — | CN | disclosed |